SCHEMBL2910107

SCHEMBL2910107

CC(C)(C)OC(=O)NCCCC(NC(=O)OC(C)(C)C)C(=O)Nc1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.42
GSK3A P49840 3/20 0.42
CDK1 P06493 2/20 0.39
CCNB2 O95067 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
BRD4 O60885 2/20 0.35
P2RY2 P41231 1/20 0.34
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
DRD2 P14416 1/20 0.33
STK17B O94768 1/20 0.33
STK17A Q9UEE5 1/20 0.33
BCL2 P10415 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904658 0.92 GSK3B (0.41) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907714 0.91 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907603 0.86 CA2 (0.35) BRD4CA1CA2BCL2HDAC4
SCHEMBL2912808 0.84 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910561 0.82 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219461 0.81 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911365 0.81 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904684 0.80 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909927 0.79 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2913657 0.79 GSK3B (0.44) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed